CROS NT SRL Announces Acquisition of Stat-Tech Services, LLC
To fulfill the need for global biometrics solutions, CROS NT SRL today announced the acquisition of Stat?Tech Services, LLC ? a Contract Research Organization (CRO) with extensive experience in the medical devices sector.
To fulfill the need for global biometrics solutions, CROS NT SRL today announced the acquisition of Stat‐Tech Services, LLC ‐ a Contract Research Organization (CRO) with extensive experience in the medical devices sector. The financial details of the transaction remain confidential.
CROS NT, an international CRO, specializes in biometrics services, and sees the acquisition as an important part of their overall strategy. The deal adds the US to Italy, Germany, and the UK; increasing CROS NT’s geographical reach while adding critical mass to its operation. Stat‐Tech has an excellent reputation for quality and service making it an obvious target for CROS NT, which is seeking to expand while maintaining service excellence.
Paolo Morelli, CEO and President of CROS NT, said, “I am delighted to welcome Stat‐Tech services into the family. The experience and quality of the Stat‐Tech team will add strong value to CROS NT, adding the important area of Medical Devices to our portfolio and allowing us to improve our services to our existing US customers by being closer to them. I was impressed by the reputation of their management and their strong leadership, which we can combine with the existing groups in Europe to field a great team globally.”
“I believe that having highly qualified specialists delivers the best results when conducting clinical trials. CROS NT remains focused on biometrics and by providing expert data services allows its customers to work with clinical CROs appropriate to their therapeutic or geographic needs. We take care of the data collection and the reporting and provide centralized data solutions to maximize the value of those data to the customer,” Paolo added.
George DeMuth, one of the founders of Stat‐Tech Services, LLC and incoming Chief Operating Officer, US Operations, said, “We are very excited about joining CROS NT. This move allows us to provide a broader range of services and additional resources to our existing clients; and provides additional opportunities for growth. CROS NT has a high level of expertise to go with a focus on quality and service; so we knew immediately Stat‐Tech was joining a great team.”
Stat‐Tech Services, LLC is based in Chapel Hill, NC and has been providing biometrics services since 1996. The company has supported numerous approvals in medical devices (501(k)s and PMAs), biologics, and pharmaceutical indications. In addition to data management, study design, and data analysis, Stat‐Tech Services has been involved in numerous FDA interactions including FDA panel meetings.
Stat‐Tech will operate as a business line within CROS NT, trading as “Stat‐Tech Services, part of CROS NT Group.” The transaction is due to complete later this month.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
